These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28713008)

  • 1. Determining myeloperoxidase activity and protein concentration in a single assay: Utility in biomarker and therapeutic studies.
    Russell M; Prokoph N; Henderson N; Eketjäll S; Balendran CA; Michaëlsson E; Fidock M; Hughes G
    J Immunol Methods; 2017 Oct; 449():76-79. PubMed ID: 28713008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunological method to combine the measurement of active and total myeloperoxidase on the same biological fluid, and its application in finding inhibitors which interact directly with the enzyme.
    Franck T; Minguet G; Delporte C; Derochette S; Zouaoui Boudjeltia K; Van Antwerpen P; Gach O; Deby-Dupont G; Mouithys-Mickalad A; Serteyn D
    Free Radic Res; 2015 Jun; 49(6):790-9. PubMed ID: 25968947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of myeloperoxidase in EDTA plasma: comparison of an enzyme-linked immunosorbent assay with a chemiluminescent automated immunoassay.
    Zelzer S; Khoschsorur G; Stettin M; Weihrauch G; Truschnig-Wilders M
    Clin Chim Acta; 2009 Aug; 406(1-2):62-5. PubMed ID: 19463803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Total, Active, and Specific Myeloperoxidase Levels in Women with and without Endometriosis.
    O DF; Waelkens E; Peterse DP; Lebovic D; Meuleman C; Tomassetti C; Peeraer K; Alvarez Real A; Bosseloir A; D'Hooghe T; Fassbender A
    Gynecol Obstet Invest; 2018; 83(2):133-139. PubMed ID: 28511185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome.
    Hanikoglu F; Huseyinoglu N; Ozben S; Cort A; Ozdem S; Ozben T
    Int J Neurosci; 2015; 125(9):655-62. PubMed ID: 25180986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery disease.
    Trentini A; Rosta V; Spadaro S; Bellini T; Rizzo P; Vieceli Dalla Sega F; Passaro A; Zuliani G; Gentili V; Campo G; Cervellati C
    Clin Chem Lab Med; 2020 Sep; 58(10):1749-1758. PubMed ID: 32031967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid bioluminescence assay for measuring myeloperoxidase activity in human plasma.
    Goiffon RJ; Martinez SC; Piwnica-Worms D
    Nat Commun; 2015 Feb; 6():6271. PubMed ID: 25666092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood.
    Franck T; Grulke S; Deby-Dupont G; Deby C; Duvivier H; Peters F; Serteyn D
    J Vet Diagn Invest; 2005 Sep; 17(5):412-9. PubMed ID: 16312231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase As a Multifaceted Target for Cardiovascular Protection.
    Ramachandra CJA; Ja KPMM; Chua J; Cong S; Shim W; Hausenloy DJ
    Antioxid Redox Signal; 2020 May; 32(15):1135-1149. PubMed ID: 31847538
    [No Abstract]   [Full Text] [Related]  

  • 10. [New approaches to the measurement of the concentration and peroxidase activity of myeloperoxidase in human blood plasma].
    Gorudko IV; Cherkalina OS; Sokolov AV; Pulina MO; Zakharova ET; Vasil'ev VB; Cherenkevich SN; Panasenko OM
    Bioorg Khim; 2009; 35(5):629-39. PubMed ID: 19915640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?
    Schindhelm RK; van der Zwan LP; Teerlink T; Scheffer PG
    Clin Chem; 2009 Aug; 55(8):1462-70. PubMed ID: 19556446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease].
    Grigorieva DV; Gorudko IV; Kostevich VA; Sokolov AV; Buko IV; Vasilyev VB; Polonetsky LZ; Panasenko OM; Cherenkevich SN
    Biomed Khim; 2016 Mar; 62(3):318-24. PubMed ID: 27420626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of myeloperoxidase in endurance and 3-day event horses after a competition.
    Art T; Franck T; Gangl M; Votion D; Kohnen S; Deby-Dupont G; Serteyn D
    Equine Vet J Suppl; 2006 Aug; (36):298-302. PubMed ID: 17402436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil myeloperoxidase measurements in plasma, laminar tissue, and skin of horses given black walnut extract.
    Riggs LM; Franck T; Moore JN; Krunkosky TM; Hurley DJ; Peroni JF; de la Rebière G; Serteyn DA
    Am J Vet Res; 2007 Jan; 68(1):81-6. PubMed ID: 17199423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma myeloperoxidase in ESRD patients.
    Wang AY; Lam CW; Chan IH; Wang M; Lui SF; Sanderson JE
    Am J Kidney Dis; 2010 Nov; 56(5):937-46. PubMed ID: 20638167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of Monoclonal Antibodies and a Simple Myeloperoxidase-Immunosorbent Assay for Detecting Human Myeloperoxidase.
    Bian ZP; Li XZ; Wu HF; Xu JD; Gu CR; Chen XJ; Yang D
    Monoclon Antib Immunodiagn Immunother; 2016 Apr; 35(2):86-93. PubMed ID: 26978734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new easy method for specific measurement of active myeloperoxidase in human biological fluids and tissue extracts.
    Franck T; Kohnen S; Boudjeltia KZ; Van Antwerpen P; Bosseloir A; Niesten A; Gach O; Nys M; Deby-Dupont G; Serteyn D
    Talanta; 2009 Dec; 80(2):723-9. PubMed ID: 19836543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an ELISA for myeloperoxidase on microplate: normal reference values and effect of temperature on specimen preparation.
    Chang PY; Wu TL; Hung CC; Tsao KC; Sun CF; Wu LL; Wu JT
    Clin Chim Acta; 2006 Nov; 373(1-2):158-63. PubMed ID: 16815352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients.
    Khalilova IS; Dickerhof N; Mocatta TJ; Bhagra CJ; McClean DR; Obinger C; Kettle AJ
    PLoS One; 2018; 13(3):e0192952. PubMed ID: 29590135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase concentration in bronchoalveolar lavage fluid from healthy horses and those with recurrent airway obstruction.
    Art T; Franck T; Lekeux P; de Moffarts B; Couëtil L; Becker M; Kohnen S; Deby-Dupont G; Serteyn D
    Can J Vet Res; 2006 Oct; 70(4):291-6. PubMed ID: 17042382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.